As expected, heparin and heparinase-reduced HBV attachment, uptake, and infection establishment in control cells and these compounds also reduced the LIPG-mediated increase of HBV attachment, uptake, and infection establishment (Figure 2D–G). The gene discussed is LIPG; the disease is infection.